Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes. - Archive ouverte HAL Access content directly
Journal Articles Mitochondrion Year : 2013

Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes.

(1, 2) , (1) , (3) , (1, 3) , (1) , (1)
1
2
3

Abstract

Contractile dysfunction and subsequent development of cardiomyopathies are well known limiting factors in the treatment of cancer with doxorubicin and have been linked to mitochondrial dysfunction. Here, using adult isolated paced cardiomyocytes, we have demonstrated that ligands of translocator protein (TSPO) 4'-chlorodiazepam and TRO40303 prevented the doxorubicin-induced alterations in contractility and improved cardiomyocyte viability. This cardioprotective effect was closely associated with both a potent reduction in reactive oxygen species production and inhibition of mitochondrial permeability transition pore opening. Thus, preventive administration of TSPO ligands may represent a novel pharmacological strategy to protect the heart during doxorubicin treatment.
Fichier principal
Vignette du fichier
article_mitochondrion_pour_dA_pA_t_sur_HAL.pdf (1.03 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00920557 , version 1 (18-12-2013)

Identifiers

Cite

Alexandra d'Anglemont de Tassigny, Rana Assaly, Sophie Schaller, Rebecca M. Pruss, Alain Berdeaux, et al.. Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes.. Mitochondrion, 2013, 13 (6), pp.688-97. ⟨10.1016/j.mito.2013.10.001⟩. ⟨inserm-00920557⟩

Collections

INSERM IMRB UPEC
402 View
750 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More